Hub : Traits :

Tanning

1554 significantly associated models · 310 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 62552269 64021096 1 1 6.6e-14 3.5e-24 1.3e-12 51 ATG4C
2 1 65294331 67944069 4 2 8.1e-23 9.6e-57 1.0e-31 46 LEPR PDE4B
3 1 119761038 120687115 2 1 5.9e-09 7.8e-12 2.7e-04 72 RP5-1042I8.7
4 1 149854324 151846517 14 8 6.9e-20 2.4e-20 1.0e+00 100 ARNT CERS2 GOLPH3L HORMAD1 RP11-316M1.12 RP11-54A4.2
5 1 154282146 156572984 17 2 2.1e-16 3.7e-18 1.0e+00 100 ADAM15 MTX1P1
6 1 204314219 205921859 5 1 1.6e-26 2.0e-38 9.1e-15 64 RBBP5
7 1 211709083 213229337 2 1 1.0e-08 9.0e-09 1.0e+00 100 RP11-15I11.3
8 2 24348096 26088769 4 7 6.0e-15 3.3e-15 NaN NaN ADCY3 DNAJC27 POMC RP11-443B20.1
9 2 26883355 28402863 4 1 7.3e-11 4.1e-14 1.1e-04 74 NRBP1
10 2 37453629 39300259 7 12 2.1e-32 1.8e-43 NaN NaN AC009229.5 ATL2 C2orf58 CYP1B1 FAM82A1 RMDN2
11 2 62211083 63968655 2 1 8.8e-09 1.5e-06 4.3e-01 97 EHBP1
12 2 171683107 173114238 1 1 1.1e-07 3.4e-16 6.1e-13 22 CYBRD1
13 3 51860817 53573517 6 1 2.5e-08 1.1e-07 4.6e-01 98 RP5-966M1.6
14 3 84317575 86808226 1 1 5.5e-13 6.8e-25 1.7e-13 49 CADM2
15 3 97736804 99315838 3 1 9.0e-10 4.0e-10 1.2e-02 84 ST3GAL6-AS1
16 3 155544380 157456920 5 10 1.8e-12 5.0e-29 NaN NaN LEKR1 LINC00886 METTL15P1 RP11-305K5.1 SSR3
17 5 12225 1214264 2 1 8.3e-11 1.8e-05 5.6e-01 98 CTD-2228K2.7
18 5 33241655 34706321 2 2 5.7e-15 0.0e+00 0.0e+00 3 AMACR RXFP3
19 5 59474215 61145102 2 2 3.6e-10 5.4e-11 3.0e-05 60 ERCC8 NDUFAF2
20 5 138753725 140337279 2 1 2.7e-08 1.5e-06 2.2e-01 93 LINC01024
21 5 176040488 177260129 2 1 7.9e-11 4.2e-10 7.2e-01 100 PRELID1
22 6 202452 1408677 3 17 3.3e-193 0.0e+00 0.0e+00 19 EXOC2 IRF4 RP11-532F6.3
23 6 35397127 36804187 1 1 1.4e-07 1.5e-08 2.7e-04 59 MAPK13
24 6 41005502 42587818 3 1 8.5e-11 5.6e-12 1.0e+00 100 MED20
25 6 51665597 53131343 1 1 2.5e-08 1.2e-08 1.8e-02 83 TRAM2
26 6 81504236 83161854 1 1 3.0e-07 1.4e-06 7.1e-05 32 FAM46A
27 6 145125929 146983441 5 1 2.4e-10 9.5e-12 9.9e-03 86 EPM2A
28 7 16622785 18084843 2 1 1.9e-08 1.1e-29 1.4e-28 4 AC003075.4
29 7 72674074 73738067 1 1 3.4e-07 3.9e-07 1.0e+00 100 MLXIPL
30 7 104060000 105736971 1 1 2.7e-07 1.3e-07 5.6e-07 10 SRPK2
31 8 41318439 42727452 1 1 2.8e-07 2.1e-07 2.9e-02 82 AP3M2
32 8 115726164 117519662 1 1 3.3e-40 1.6e-98 4.3e-60 40 TRPS1
33 8 144294773 145744618 2 1 2.2e-09 7.5e-08 3.1e-01 96 PARP10
34 9 11988659 13977570 4 4 9.2e-63 3.0e-81 1.5e-14 84 LURAP1L MPDZ RP11-3L8.3 TYRP1
35 9 15714465 18201083 2 5 1.1e-54 1.7e-232 2.0e-150 36 BNC2 CNTLN
36 9 26851195 28272794 1 1 3.5e-10 9.9e-10 9.1e-02 92 C9orf72
37 10 5039564 6576881 2 1 2.1e-14 9.5e-13 7.3e-01 100 GDI2
38 10 63856856 65606229 3 1 1.2e-13 1.7e-13 2.1e-02 90 NRBF2
39 10 101213253 102632622 1 1 2.1e-07 5.2e-11 4.1e-11 -1 ERLIN1
40 10 118347262 119829043 1 1 4.0e-08 2.8e-95 1.2e-91 4 PDZD8
41 11 15288270 17459851 1 1 3.7e-11 9.6e-14 2.4e-04 76 SOX6
42 11 54801549 55948667 1 1 1.4e-08 4.6e-02 2.6e-02 -25 OR4A21P
43 11 67833543 69626918 7 9 5.6e-55 4.0e-49 NaN NaN IGHMBP2 RP11-554A11.9 TPCN2
44 11 77027574 78979645 5 1 1.6e-10 3.1e-11 2.9e-02 89 USP35
45 11 87146898 90616949 5 13 2.1e-34 0.0e+00 0.0e+00 34 CTSC NAALAD2 NOX4 RAB38 RP11-81M19.3
46 12 40388337 42165804 1 1 1.1e-09 7.6e-10 1.0e+00 100 CNTN1
47 12 55933641 57318731 1 1 1.4e-08 1.0e-06 2.9e-02 80 OBFC2B
48 12 87747907 89262140 2 3 1.1e-35 1.2e-38 1.3e-03 94 TMTC3
49 12 124700826 126101198 1 1 1.9e-09 1.3e-14 7.0e-07 59 UBC
50 13 94398894 95827872 1 1 2.4e-16 3.7e-18 6.8e-04 85 DCT
51 13 112852538 114502416 2 2 9.8e-08 8.7e-72 7.6e-61 16 AL356740.1 F10
52 14 77106456 78542305 1 1 1.7e-07 4.6e-05 4.2e-01 96 TMED8
53 14 91738696 93201999 1 1 1.7e-08 6.9e-55 4.7e-48 13 TRIP11
54 15 27302102 28535266 2 4 6.4e-283 8.1e-305 5.7e-85 73 HERC2 OCA2
55 15 28958739 29615111 1 1 7.7e-52 2.5e-17 4.6e-13 27 HERC2P9
56 16 13315655 14742400 1 1 2.2e-12 1.4e-15 2.0e-14 8 ERCC4
57 16 71070698 72838680 3 1 4.5e-10 3.6e-12 1.3e-03 78 IST1
58 16 87834943 90172696 53 33 0.0e+00 0.0e+00 NaN NaN ACSF3 ANKRD11 APRT CENPBD1 CHMP1A CTU2 CYBA DBNDD1 DEF8 FANCA GALNS GAS8 RNF166 RP11-46C24.7 RP11-566K11.5 RPL13 SNAI3-AS1 SPIRE2 TRAPPC2L VPS9D1 ZFPM1
59 17 45483229 46899254 1 1 1.4e-09 4.3e-06 8.6e-01 100 SNX11
60 17 78778692 80357420 6 3 2.7e-12 1.7e-21 6.9e-05 82 ACTG1 HGS TSPAN10
61 20 20795202 22188798 1 1 3.8e-07 2.4e-07 1.0e+00 100 NKX2-2
62 20 29833609 36642760 64 40 0.0e+00 0.0e+00 NaN NaN BCL2L1 CBFA2T2 CHMP4B COMMD7 DLGAP4 E2F1 GDF5 KIF3B MANBAL MAP1LC3A MAPRE1 MMP24 MMP24-AS1 MROH8 NCOA6 NDRG3 PROCR PXMP4 RALY RBL1 RBM39 RP5-1085F17.3 RPN2 SAMHD1 SOGA1 TLDC2 TP53INP2 TRPC4AP TSPY26P
63 22 37337772 40479448 7 4 1.6e-12 5.2e-13 7.9e-01 100 MAFF SH3BP1 SYNGR1
64 22 44835936 46334133 5 4 1.7e-27 1.8e-65 3.5e-30 55 C22orf9 KIAA0930 LOC100506714 NUP50

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 1.37 5 3 9.1 0.37 4.8e-01 ADCY3 MTX1P1 NRBP1 RP11-443B20.1 SYNGR1
Irritable Bowel Disease (IBD) 1.63 11 5 15.2 0.44 1.3e-01 ADCY3 ARNT CERS2 HORMAD1 KIF3B MTX1P1 NRBP1 RP11-316M1.12 RP11-443B20.1 SYNGR1 TSPY26P
Reaction Time 0.97 1 0 0.0 0.00 1.0e+00 ADCY3
Verbal and Numeric Reasoning (VNR) 1.00 2 1 3.0 0.00 1.0e+00 LINC01024 RP5-966M1.6
Breast Cancer 1.59 7 5 15.2 0.26 3.9e-01 ADCY3 GDI2 LINC00886 MAFF MTX1P1 RP11-443B20.1 RP11-554A11.9
Prostate Cancer 2.48 4 2 6.1 -0.39 3.5e-01 ADAM15 CERS2 EHBP1 RP11-554A11.9
Bipolar Disorder 1.30 1 0 0.0 0.00 1.0e+00 RP5-966M1.6
Body Mass Index (BMI) (2010) 1.20 2 1 3.0 0.00 1.0e+00 ADCY3 RP11-443B20.1
Crohns Disease (2012) 1.08 1 0 0.0 0.00 1.0e+00 MTX1P1
Fasting Glucose 1.03 1 1 3.0 0.00 1.0e+00 NRBP1
HDL Cholesterol 1.22 3 2 6.1 0.00 1.0e+00 MLXIPL SYNGR1 TRPS1
LDL Cholesterol 0.98 2 0 0.0 0.00 1.0e+00 ATG4C PARP10
Primary Biliary Cirrhosis 1.39 1 1 3.0 0.00 1.0e+00 SYNGR1
Rheumatoid Arthritis 0.99 1 0 0.0 0.00 1.0e+00 SYNGR1
Schizophrenia 1.03 3 1 3.0 0.00 1.0e+00 ERCC8 NDUFAF2 RP5-966M1.6
Triglycerides 2.86 7 6 18.2 0.13 7.8e-01 ATG4C MAFF MLXIPL NCOA6 NRBF2 NRBP1 TP53INP2
Type 2 Diabetes (T2D) 1.28 1 0 0.0 0.00 1.0e+00 RAB38
Blood Eosinophil Count 1.01 20 11 33.3 0.54 5.6e-03 ADAM15 ADCY3 ARNT BCL2L1 CERS2 CTSC EXOC2 GOLPH3L HORMAD1 MAPK13 RP11-316M1.12 RP11-443B20.1 RP5-966M1.6 RPL13 SOGA1 SOX6 ST3GAL6-AS1 TMED8 TSPY26P ZFPM1
Blood Platelet Count 1.33 31 20 60.6 -0.07 6.8e-01 ADAM15 ARNT CBFA2T2 CERS2 CTU2 E2F1 GALNS HORMAD1 KIF3B LEPR MAP1LC3A MAPRE1 MED20 MLXIPL MTX1P1 NCOA6 NRBF2 NRBP1 PARP10 PXMP4 RALY RBBP5 RP11-316M1.12 RP11-554A11.9 RP5-966M1.6 RPL13 SYNGR1 TRAM2 TRAPPC2L VPS9D1 ZFPM1
Blood Red Count 0.67 25 13 39.4 0.06 7.6e-01 ACTG1 ADAM15 BCL2L1 CHMP4B DEF8 F10 GALNS HGS MAFF MAP1LC3A MED20 NCOA6 OBFC2B PARP10 RBBP5 RNF166 RP11-15I11.3 RP5-1085F17.3 RP5-966M1.6 SH3BP1 TMTC3 TRAPPC2L TSPY26P USP35 VPS9D1
Blood White Count 0.80 13 8 24.2 0.21 4.7e-01 ARNT LEPR MLXIPL NRBF2 NRBP1 RALY RP11-443B20.1 RP11-554A11.9 SRPK2 TMED8 TMTC3 TPCN2 VPS9D1
Heel T-Score 1.67 34 21 63.6 -0.18 2.6e-01 ACSF3 ANKRD11 ARNT BNC2 DBNDD1 DNAJC27 E2F1 EPM2A FANCA GAS8 GDF5 HGS HORMAD1 IGHMBP2 LEKR1 LINC00886 MAP1LC3A METTL15P1 NCOA6 OR4A21P PXMP4 RALY RP11-316M1.12 RP11-554A11.9 RPL13 SH3BP1 SOX6 SSR3 TPCN2 TRPC4AP TRPS1 TSPAN10 USP35 VPS9D1
BMI 1.85 23 11 33.3 0.02 9.3e-01 ADAM15 ADCY3 CADM2 DEF8 DNAJC27 EHBP1 F10 IGHMBP2 MANBAL MED20 MLXIPL NCOA6 NRBF2 POMC RALY RP11-443B20.1 RP11-81M19.3 RP5-966M1.6 SH3BP1 SNX11 TRPC4AP TSPY26P USP35
Height 2.97 77 61 184.8 0.34 6.0e-04 AC003075.4 AC009229.5 ACSF3 ACTG1 ADAM15 ADCY3 ARNT ATG4C CBFA2T2 CHMP1A CHMP4B CNTLN CTU2 CYBRD1 CYP1B1 DBNDD1 DNAJC27 E2F1 EPM2A ERLIN1 EXOC2 FAM46A FANCA GAS8 GDF5 GDI2 IST1 LINC00886 MAFF MANBAL MAP1LC3A MAPK13 MAPRE1 MED20 MLXIPL MMP24 MMP24-AS1 MROH8 NAALAD2 NCOA6 NKX2-2 NOX4 NRBP1 OBFC2B PARP10 POMC PRELID1 PROCR PXMP4 RALY RBM39 RMDN2 RP11-15I11.3 RP11-305K5.1 RP11-443B20.1 RP11-532F6.3 RP11-554A11.9 RP5-966M1.6 RPL13 RPN2 SAMHD1 SH3BP1 SNAI3-AS1 SNX11 SOX6 SRPK2 SSR3 ST3GAL6-AS1 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 UBC USP35 VPS9D1 ZFPM1
Waist Hip Ratio (WHR) 1.12 11 6 18.2 -0.03 9.3e-01 ADAM15 CYBRD1 GDF5 LINC00886 MLXIPL NKX2-2 RP11-15I11.3 RP11-443B20.1 RP11-554A11.9 RP5-966M1.6 TPCN2
Systolic Blood Pressure 1.07 9 6 18.2 0.30 3.5e-01 ADCY3 CADM2 DNAJC27 GDF5 NRBF2 NRBP1 RP11-443B20.1 SNX11 TSPY26P
Smoking Status 1.11 3 1 3.0 0.00 1.0e+00 CADM2 LEPR RP5-966M1.6
Allergy or Eczema 0.96 4 2 6.1 0.61 3.9e-01 ADAM15 NRBF2 NRBP1 OR4A21P
Cardiovascular Disease 1.12 7 3 9.1 0.14 7.0e-01 BCL2L1 FANCA MLXIPL NRBF2 NRBP1 PRELID1 TSPY26P
Hypothyroidism (self reported) 1.05 2 0 0.0 0.00 1.0e+00 EXOC2 SYNGR1
Type 2 Diabetes (T2D) 1.25 4 3 9.1 0.75 2.5e-01 CHMP4B ERLIN1 NRBP1 RP5-1042I8.7
Lung FEV1/FVC ratio 1.68 20 13 39.4 -0.16 3.7e-01 ACTG1 ADAM15 ADCY3 CYBRD1 EXOC2 GDF5 LINC00886 MAP1LC3A NRBF2 RALY RBBP5 RP11-305K5.1 RP11-443B20.1 RP11-532F6.3 RP5-1085F17.3 RP5-966M1.6 SNX11 SSR3 TSPY26P USP35
Lung FVC 1.56 20 13 39.4 -0.41 4.4e-02 ACTG1 ARNT CERS2 CTU2 EHBP1 GDF5 HORMAD1 IGHMBP2 MAPK13 MMP24 MMP24-AS1 NCOA6 NOX4 NRBF2 RALY RBM39 RP11-316M1.12 TP53INP2 TRPC4AP TSPY26P
Neuroticism 1.19 8 1 3.0 -0.78 1.3e-02 ACTG1 CADM2 LEKR1 NCOA6 RNF166 SNAI3-AS1 TP53INP2 USP35
Chronotype (morning person) 1.19 5 2 6.1 -0.27 6.0e-01 CERS2 HORMAD1 PDE4B RP11-316M1.12 RP11-443B20.1
Hair Pigment 27.41 88 80 242.4 -0.80 5.0e-32 ACSF3 ACTG1 ADCY3 ANKRD11 AP3M2 APRT BCL2L1 BNC2 C9orf72 CBFA2T2 CENPBD1 CHMP1A CHMP4B CNTLN COMMD7 CTSC CTU2 CYBA DBNDD1 DCT DEF8 DLGAP4 E2F1 EXOC2 FANCA GALNS GAS8 GDF5 HERC2 HERC2P9 HGS IGHMBP2 IRF4 LINC00886 LURAP1L MANBAL MAP1LC3A MAPRE1 MLXIPL MMP24 MMP24-AS1 MPDZ MROH8 MTX1P1 NAALAD2 NCOA6 NDRG3 NOX4 NRBP1 OCA2 OR4A21P PROCR PXMP4 RALY RBBP5 RBL1 RBM39 RNF166 RP11-3L8.3 RP11-443B20.1 RP11-46C24.7 RP11-532F6.3 RP11-54A4.2 RP11-554A11.9 RP11-566K11.5 RP11-81M19.3 RP5-1085F17.3 RXFP3 SAMHD1 SNAI3-AS1 SNX11 SOGA1 SOX6 SPIRE2 SYNGR1 TLDC2 TMTC3 TP53INP2 TPCN2 TRAPPC2L TRIP11 TRPC4AP TSPAN10 TSPY26P TYRP1 USP35 VPS9D1 ZFPM1
Hand grip strength (left) 1.85 9 6 18.2 -0.84 3.4e-04 ADCY3 CADM2 GDF5 MAP1LC3A MMP24 MMP24-AS1 RBM39 RP11-443B20.1 SNX11
Number of treatments/medications taken 1.14 2 0 0.0 0.00 1.0e+00 NRBP1 TSPY26P
Relative age of first facial hair 1.72 2 2 6.1 0.00 1.0e+00 DBNDD1 HERC2
Systolic blood pressure, automated reading 0.80 3 2 6.1 0.00 1.0e+00 NRBF2 RP11-443B20.1 SNX11
Vitamin and mineral supplements 1.20 1 0 0.0 0.00 1.0e+00 RP11-81M19.3
Medication: Metformin 1.00 1 0 0.0 0.00 1.0e+00 NRBP1
Impedance of leg (right) 1.88 31 15 45.5 0.36 3.4e-02 ADAM15 ADCY3 ANKRD11 ARNT CADM2 CYBRD1 GDF5 HORMAD1 IGHMBP2 LOC100506714 MAPRE1 MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 POMC PRELID1 PROCR PXMP4 RALY RBM39 RNF166 RP11-15I11.3 RP11-443B20.1 RP11-54A4.2 RP5-966M1.6 SOX6 TP53INP2 TPCN2 TSPAN10
Leg fat-free mass (left) 2.53 36 21 63.6 -0.50 8.6e-04 ACSF3 ACTG1 ADAM15 ANKRD11 CADM2 CBFA2T2 CYBRD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NRBP1 OBFC2B PARP10 POMC PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNAI3-AS1 SNX11 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1
Trunk fat percentage 1.37 10 6 18.2 -0.04 9.0e-01 ADCY3 ARNT DBNDD1 DEF8 DNAJC27 MAFF MAPK13 POMC RP11-443B20.1 SNX11
Hand grip strength (right) 1.97 11 8 24.2 -0.58 2.4e-02 ADCY3 ANKRD11 GDF5 MAP1LC3A METTL15P1 MMP24 MMP24-AS1 RBM39 RP11-443B20.1 RP11-54A4.2 RPL13
Fed-up feelings 0.91 2 0 0.0 0.00 1.0e+00 RNF166 TRPS1
Relative age voice broke 1.29 1 0 0.0 0.00 1.0e+00 GDF5
Taking other prescription medications 1.18 2 0 0.0 0.00 1.0e+00 CHMP1A TSPY26P
Age when periods started (menarche) 1.08 5 3 9.1 -0.71 1.1e-01 ADCY3 LEPR RP11-443B20.1 RP5-966M1.6 USP35
Heel bone mineral density (BMD) T-score, automated (left) 1.52 4 3 9.1 0.67 7.0e-02 LEKR1 LINC00886 TPCN2 TRPC4AP
Qualifications: CSEs or equivalent 1.22 1 0 0.0 0.00 1.0e+00 KIF3B
High blood pressure 0.89 3 2 6.1 -0.40 5.0e-01 BCL2L1 NRBF2 TSPY26P
Hayfever, allergic rhinitis or eczema 0.95 2 0 0.0 0.00 1.0e+00 NRBP1 RP5-1085F17.3
Multivitamins +/- minerals 1.33 2 0 0.0 0.00 1.0e+00 RALY RP11-81M19.3
Supplements: Glucosamine 0.90 1 1 3.0 0.00 1.0e+00 NRBF2
Sitting height 3.42 38 25 75.8 -0.53 2.5e-04 ACTG1 ADAM15 ADCY3 CBFA2T2 CHMP4B DBNDD1 DNAJC27 E2F1 FAM46A GDF5 KIF3B MAFF MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NKX2-2 NRBP1 OBFC2B PARP10 POMC PRELID1 PROCR PXMP4 RALY RBM39 RP11-15I11.3 RP11-443B20.1 RP5-966M1.6 RPL13 SH3BP1 SNAI3-AS1 ST3GAL6-AS1 TP53INP2 TPCN2 TRPS1
Body mass index (BMI) 1.65 11 8 24.2 0.26 3.7e-01 ADAM15 ADCY3 CADM2 DNAJC27 EHBP1 IGHMBP2 MED20 POMC RALY RP11-443B20.1 RP5-966M1.6
Impedance of leg (left) 1.84 29 16 48.5 0.32 6.7e-02 ADAM15 ADCY3 ANKRD11 ARNT CADM2 CYBRD1 GDF5 HORMAD1 IGHMBP2 LOC100506714 MED20 MLXIPL MMP24-AS1 NCOA6 NRBP1 POMC PRELID1 PROCR PXMP4 RALY RBM39 RP11-15I11.3 RP11-443B20.1 RP11-54A4.2 RP5-966M1.6 RPL13 SOX6 TP53INP2 TPCN2
Leg predicted mass (left) 2.53 36 21 63.6 -0.50 1.1e-03 ACSF3 ACTG1 ADAM15 ANKRD11 CADM2 CBFA2T2 CYBRD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NRBP1 OBFC2B PARP10 POMC PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNAI3-AS1 SNX11 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1
Trunk fat mass 1.40 13 8 24.2 -0.31 2.2e-01 ADCY3 DBNDD1 DEF8 E2F1 EHBP1 GDF5 IGHMBP2 MAFF MAPK13 POMC PXMP4 RP11-443B20.1 SNX11
Waist circumference 1.34 8 4 12.1 0.57 8.2e-02 ADAM15 ADCY3 CADM2 EHBP1 NRBF2 POMC RP11-443B20.1 SNX11
Past tobacco smoking 1.20 2 1 3.0 0.00 1.0e+00 CADM2 RP11-443B20.1
Alcohol usually taken with meals 1.05 1 0 0.0 0.00 1.0e+00 SRPK2
Nervous feelings 1.17 4 3 9.1 0.83 7.9e-02 CADM2 NCOA6 RP5-966M1.6 TP53INP2
Hearing difficulty/problems with background noise 0.93 1 0 0.0 0.00 1.0e+00 PRELID1
Had menopause 1.15 2 1 3.0 0.00 1.0e+00 NRBP1 VPS9D1
Forced vital capacity (FVC) 1.64 16 9 27.3 -0.50 2.0e-02 ADCY3 ARNT DBNDD1 E2F1 GDF5 HORMAD1 IST1 MAPK13 MMP24-AS1 NOX4 OBFC2B PRELID1 PXMP4 RP11-316M1.12 RP11-443B20.1 TPCN2
Heel bone mineral density (BMD) T-score, automated (right) 1.39 5 3 9.1 0.71 3.4e-02 EPM2A LEKR1 LINC00886 TPCN2 TRPC4AP
Qualifications: None of the above 0.78 1 0 0.0 0.00 1.0e+00 IST1
Mouth/teeth dental problems 0.98 1 0 0.0 0.00 1.0e+00 RBBP5
Allergy 1.05 1 0 0.0 0.00 1.0e+00 RP5-1085F17.3
Diabetes (self-reported) 1.44 3 2 6.1 0.00 1.0e+00 CHMP4B NRBP1 RP5-1042I8.7
Medication: Simvastatin 0.79 1 0 0.0 0.00 1.0e+00 NRBP1
Fluid intelligence score 0.97 1 0 0.0 0.00 1.0e+00 LINC01024
Illnesses of siblings 1.05 1 0 0.0 0.00 1.0e+00 NRBF2
Neuroticism score 1.06 3 1 3.0 0.00 1.0e+00 CADM2 NCOA6 TP53INP2
Weight 1.89 31 18 54.5 -0.39 2.1e-02 ADAM15 ADCY3 CADM2 DBNDD1 E2F1 EHBP1 GDF5 IGHMBP2 IRF4 MAFF MAP1LC3A MED20 MLXIPL MMP24-AS1 NCOA6 NRBP1 PARP10 POMC PRELID1 PROCR PXMP4 RALY RBM39 RP11-443B20.1 RPL13 RPN2 SNX11 SYNGR1 TP53INP2 TRPS1 TYRP1
Impedance of arm (right) 1.76 29 18 54.5 0.07 7.0e-01 ADAM15 ANKRD11 ARNT CADM2 CERS2 DBNDD1 HORMAD1 IGHMBP2 LINC00886 MAFF MANBAL MED20 MLXIPL NCOA6 NRBF2 NRBP1 PRELID1 PROCR RALY RP11-15I11.3 RP11-316M1.12 RP11-54A4.2 RP11-554A11.9 RP5-966M1.6 RPL13 TP53INP2 TRPC4AP TSPY26P USP35
Arm fat percentage (right) 1.66 6 6 18.2 0.73 3.8e-02 ADCY3 DNAJC27 MAFF MAPK13 POMC RP11-443B20.1
Trunk fat-free mass 2.94 37 25 75.8 -0.43 4.8e-03 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NKX2-2 NOX4 NRBP1 OBFC2B PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNX11 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1 VPS9D1
Hip circumference 1.68 19 12 36.4 -0.44 4.2e-02 ADAM15 ADCY3 CADM2 DNAJC27 E2F1 EHBP1 GDF5 MAFF MED20 MLXIPL MMP24-AS1 NCOA6 POMC PROCR PXMP4 RALY RP11-443B20.1 SNX11 TPCN2
Alcohol intake versus 10 years previously 1.18 1 0 0.0 0.00 1.0e+00 NRBP1
Worrier / anxious feelings 1.26 4 2 6.1 0.11 8.9e-01 CADM2 OR4A21P RP5-966M1.6 SNAI3-AS1
Number of live births 0.90 1 0 0.0 0.00 1.0e+00 DBNDD1
Forced expiratory volume in 1-second (FEV1) 1.58 12 4 12.1 -0.56 4.7e-02 ADCY3 ARNT DBNDD1 GDF5 HORMAD1 IGHMBP2 MAPK13 NOX4 NRBF2 RP11-443B20.1 TPCN2 TSPY26P
Pulse rate 0.99 1 0 0.0 0.00 1.0e+00 NRBP1
Qualifications: A levels/AS levels or equivalent 0.80 1 0 0.0 0.00 1.0e+00 SRPK2
Mouth/teeth dental problems: Dentures 1.46 3 0 0.0 0.00 1.0e+00 ADCY3 NCOA6 SNX11
Asthma 1.10 1 0 0.0 0.00 1.0e+00 TRAPPC2L
Medication: Cholesterol lowering 1.09 1 1 3.0 0.00 1.0e+00 NRBP1
Forced expiratory volume in 1-second (FEV1), Best measure 1.48 12 6 18.2 -0.68 5.2e-03 ADCY3 ARNT GDF5 HORMAD1 MAPK13 MMP24-AS1 NOX4 NRBF2 OBFC2B RBM39 RP11-443B20.1 TSPY26P
Impedance of arm (left) 1.66 30 12 36.4 0.09 6.4e-01 ADAM15 ANKRD11 ARNT CADM2 CERS2 DBNDD1 HORMAD1 IGHMBP2 LINC00886 MAFF MED20 MLXIPL NCOA6 NKX2-2 NRBF2 NRBP1 PRELID1 PROCR PXMP4 RALY RBBP5 RP11-15I11.3 RP11-316M1.12 RP11-54A4.2 RP11-554A11.9 RP5-966M1.6 TP53INP2 TRPC4AP TSPY26P USP35
Arm fat mass (right) 1.52 14 7 21.2 -0.02 9.3e-01 ADAM15 ADCY3 CADM2 DNAJC27 EHBP1 GDF5 IGHMBP2 MAFF MED20 POMC PXMP4 RALY RP11-443B20.1 SNX11
Trunk predicted mass 2.95 37 25 75.8 -0.43 4.7e-03 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NKX2-2 NOX4 NRBP1 OBFC2B PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNX11 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1 VPS9D1
Standing height 2.98 52 35 106.1 -0.40 1.2e-03 AC009229.5 ACSF3 ACTG1 ADAM15 ADCY3 CBFA2T2 CHMP1A CHMP4B CYP1B1 DBNDD1 DNAJC27 E2F1 EPM2A ERLIN1 FAM46A FANCA GAS8 GDF5 GDI2 LINC00886 MAFF MANBAL MAP1LC3A MED20 MMP24 MMP24-AS1 NAALAD2 NCOA6 NOX4 NRBP1 OBFC2B PARP10 POMC PRELID1 PROCR PXMP4 RALY RBM39 RP11-15I11.3 RP11-443B20.1 RP5-966M1.6 RPL13 RXFP3 SH3BP1 SNAI3-AS1 SNX11 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 VPS9D1
Tense / 'highly strung' 1.07 3 2 6.1 0.00 1.0e+00 CADM2 NCOA6 TP53INP2
Hair/balding pattern: Pattern 4 0.92 4 0 0.0 0.49 5.1e-01 DBNDD1 MAP1LC3A MAPRE1 RALY
Birth weight of first child 1.10 2 1 3.0 0.00 1.0e+00 MAPK13 SSR3
Peak expiratory flow (PEF) 1.69 5 2 6.1 -0.30 5.7e-01 ANKRD11 GDF5 MAP1LC3A MMP24-AS1 TRPS1
Qualifications: O levels/GCSEs or equivalent 0.89 1 0 0.0 0.00 1.0e+00 SRPK2
Medication: Paracetamol 1.07 1 0 0.0 0.00 1.0e+00 TMTC3
Headache pain in last month 1.07 4 0 0.0 -0.58 4.2e-01 KIF3B RP11-54A4.2 RP5-966M1.6 TSPY26P
Medication for cholesterol, blood pressure or diabetes 1.04 2 1 3.0 -0.58 3.1e-01 CHMP4B TSPY26P
Gout (self-reported) 1.21 3 2 6.1 0.00 1.0e+00 ADAM15 MLXIPL NRBP1
Hypothyroidism/myxoedema (self-reported) 0.98 2 0 0.0 0.00 1.0e+00 EXOC2 SYNGR1
Birth weight 1.25 5 1 3.0 0.37 5.4e-01 ADAM15 MAPK13 MTX1P1 NAALAD2 RP5-1085F17.3
High blood pressure (siblings) 1.20 1 1 3.0 0.00 1.0e+00 NRBF2
Forced vital capacity (FVC), Best measure 1.63 15 9 27.3 -0.69 7.4e-04 ADCY3 ARNT E2F1 GDF5 HORMAD1 IST1 MAPK13 MMP24-AS1 NOX4 OBFC2B PRELID1 PXMP4 RBM39 RP11-316M1.12 RP11-443B20.1
Body fat percentage 1.49 9 6 18.2 0.05 8.7e-01 ADCY3 ARNT DBNDD1 DEF8 DNAJC27 MAFF MAPK13 POMC RP11-443B20.1
Leg fat percentage (right) 1.70 9 7 21.2 0.65 1.6e-02 ADCY3 DNAJC27 GDF5 MAFF MAPK13 MMP24 POMC RBM39 RP11-443B20.1
Arm fat-free mass (right) 2.72 33 23 69.7 -0.41 9.7e-03 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 E2F1 GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NRBP1 OBFC2B PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNX11 TLDC2 TP53INP2 TPCN2 TRPS1 TYRP1 VPS9D1
Comparative body size at age 10 3.84 7 5 15.2 0.15 6.8e-01 ADCY3 CADM2 DNAJC27 LEPR NCOA6 POMC RP11-443B20.1
Worry too long after embarrassment 1.38 4 1 3.0 0.84 7.5e-02 CHMP1A DBNDD1 NKX2-2 TP53INP2
Wheeze or whistling in the chest in last year 1.21 1 0 0.0 0.00 1.0e+00 TRAPPC2L
Number of children fathered 1.12 1 0 0.0 0.00 1.0e+00 CADM2
Qualifications: College or University degree 0.79 2 1 3.0 0.00 1.0e+00 GDF5 IST1
Mouth/teeth dental problems: Loose teeth 1.08 1 0 0.0 0.00 1.0e+00 DNAJC27
Neck or shoulder pain in last month 1.22 1 0 0.0 0.00 1.0e+00 COMMD7
Medication: Blood pressure 1.21 2 1 3.0 -0.98 2.7e-03 BCL2L1 TSPY26P
Medication: Allopurinol 1.09 3 2 6.1 0.00 1.0e+00 ADAM15 MLXIPL NRBP1
Mean time to correctly identify matches 0.90 1 0 0.0 0.00 1.0e+00 SRPK2
Whole body fat mass 1.40 14 6 18.2 -0.20 4.5e-01 ADAM15 ADCY3 CADM2 DBNDD1 DNAJC27 EHBP1 GDF5 MAFF MAPK13 POMC PXMP4 RALY RP11-443B20.1 SNX11
Leg fat mass (right) 1.47 10 5 15.2 -0.10 7.5e-01 ADAM15 ADCY3 CADM2 DNAJC27 MAFF POMC PXMP4 RALY RP11-443B20.1 TSPY26P
Arm predicted mass (right) 2.70 32 23 69.7 -0.54 7.1e-04 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 E2F1 GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NRBP1 PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNX11 TLDC2 TP53INP2 TPCN2 TRPS1 TSPY26P TYRP1
Pulse rate, automated reading 1.17 7 1 3.0 0.75 5.1e-02 CNTLN LEKR1 LINC00886 MLXIPL NRBP1 SNAI3-AS1 USP35
Alcohol intake frequency. 1.06 4 4 12.1 0.73 2.7e-01 CADM2 IST1 MLXIPL NRBP1
Comparative height size at age 10 2.39 31 22 66.7 -0.44 8.3e-03 ADAM15 ADCY3 CBFA2T2 DNAJC27 E2F1 FAM46A GDF5 MAFF MANBAL MAP1LC3A MAPRE1 MMP24 MMP24-AS1 NAALAD2 NCOA6 NRBP1 PARP10 PRELID1 PROCR PXMP4 RBM39 RP11-443B20.1 RP5-966M1.6 RPN2 SNX11 ST3GAL6-AS1 TLDC2 TMED8 TRIP11 TRPS1 VPS9D1
Number of full sisters 1.11 1 0 0.0 0.00 1.0e+00 NRBF2
Suffer from 'nerves' 0.82 1 1 3.0 0.00 1.0e+00 CADM2
Overall health rating 1.15 1 0 0.0 -0.65 3.5e-01 TSPY26P
Qualifications: NVQ or HND or HNC or equivalent 1.19 1 0 0.0 0.00 1.0e+00 KIF3B
Knee pain experienced in last month 1.71 1 1 3.0 0.00 1.0e+00 GDF5
Hypertension (Self-reported) 0.92 4 2 6.1 -0.28 5.9e-01 BCL2L1 FANCA NRBF2 TSPY26P
Smoking status: Previous 1.14 1 1 3.0 0.00 1.0e+00 CADM2
Forced expiratory volume in 1-second (FEV1), predicted 2.23 11 9 27.3 -0.65 8.3e-03 ADCY3 DBNDD1 E2F1 GDF5 MMP24 MMP24-AS1 NCOA6 OBFC2B PXMP4 RBM39 RP11-443B20.1
Whole body fat-free mass 2.83 37 22 66.7 -0.51 6.2e-04 ACTG1 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NKX2-2 NRBP1 OBFC2B PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNAI3-AS1 SNX11 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1
Leg fat-free mass (right) 2.65 35 21 63.6 -0.51 7.0e-04 ACSF3 ACTG1 ADAM15 ANKRD11 CADM2 CBFA2T2 CYBRD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NRBP1 OBFC2B PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNAI3-AS1 SNX11 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1
Arm fat percentage (left) 1.68 6 6 18.2 0.73 3.8e-02 ADCY3 DNAJC27 MAFF MAPK13 POMC RP11-443B20.1
Average weekly red wine intake 1.32 1 0 0.0 0.00 1.0e+00 CADM2
Long-standing illness, disability or infirmity 1.05 1 0 0.0 0.00 1.0e+00 KIF3B
Diabetes diagnosed by doctor 1.34 3 3 9.1 0.00 1.0e+00 CHMP4B NRBP1 RP5-1042I8.7
Mouth/teeth dental problems: Mouth ulcers 1.30 3 1 3.0 -0.99 5.6e-04 ARNT HORMAD1 RP11-316M1.12
Mineral and other dietary supplements 1.04 1 0 0.0 0.00 1.0e+00 NRBF2
Asthma (self-reported) 1.11 1 0 0.0 0.00 1.0e+00 TRAPPC2L
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.22 2 0 0.0 0.00 1.0e+00 LINC01024 NRBF2
Whole body water mass 2.83 35 23 69.7 -0.51 8.2e-04 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NKX2-2 NRBP1 OBFC2B PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNX11 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1
Leg predicted mass (right) 2.65 35 22 66.7 -0.51 7.3e-04 ACSF3 ACTG1 ADAM15 ANKRD11 CADM2 CBFA2T2 CYBRD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NRBP1 OBFC2B PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNAI3-AS1 SNX11 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1
Arm fat mass (left) 1.53 14 8 24.2 -0.01 9.6e-01 ADAM15 ADCY3 CADM2 DNAJC27 EHBP1 GDF5 IGHMBP2 MAFF MED20 POMC PXMP4 RALY RP11-443B20.1 SNX11
Number of self-reported non-cancer illnesses 1.02 1 0 0.0 0.00 1.0e+00 NRBP1
Medication: Blood pressure 1.00 2 0 0.0 0.00 1.0e+00 CYP1B1 NRBF2
Pain type(s) experienced in last month: Hip pain 1.27 1 0 0.0 0.00 1.0e+00 TSPY26P
Supplements: Fish oil (including cod liver oil) 1.23 1 1 3.0 0.00 1.0e+00 RP11-81M19.3
High cholesterol (Self-reported) 1.16 1 1 3.0 0.00 1.0e+00 NRBP1
Medication: Lisinopril 1.41 2 0 0.0 0.00 1.0e+00 NRBF2 TRAPPC2L
Medication: Atorvastatin 1.21 1 1 3.0 0.00 1.0e+00 NRBP1
Ever smoked 1.09 1 1 3.0 0.00 1.0e+00 CADM2
Basal metabolic rate 2.61 38 24 72.7 -0.42 5.0e-03 ACTG1 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 DBNDD1 E2F1 FAM46A GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NKX2-2 NRBP1 OBFC2B PARP10 POMC PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNX11 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1
Leg fat percentage (left) 1.65 9 7 21.2 0.64 1.8e-02 ADCY3 DNAJC27 GDF5 MAFF MAPK13 MMP24 POMC RBM39 RP11-443B20.1
Arm fat-free mass (left) 2.64 36 22 66.7 -0.42 7.7e-03 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 E2F1 EHBP1 GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NKX2-2 NRBP1 PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNX11 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 TSPY26P TYRP1 VPS9D1
Irritability 1.34 2 2 6.1 0.00 1.0e+00 NCOA6 TP53INP2
Risk taking 1.15 1 1 3.0 0.00 1.0e+00 CADM2
Fractured/broken bones in last 5 years 0.94 1 0 0.0 0.00 1.0e+00 TPCN2
Diastolic blood pressure, automated reading 0.96 3 1 3.0 0.00 1.0e+00 DLGAP4 NRBF2 RP11-566K11.5
Vascular/heart problems diagnosed by doctor 0.94 3 2 6.1 0.46 3.6e-01 BCL2L1 NRBF2 TSPY26P
Cholesterol lowering medication 0.93 1 1 3.0 0.00 1.0e+00 NRBP1
Pain experienced in last month 1.45 3 1 3.0 0.00 1.0e+00 COMMD7 KIF3B TSPY26P
Basal cell carcinoma (self-reported) 2.94 3 2 6.1 0.98 2.2e-02 DBNDD1 NCOA6 TP53INP2
Impedance of whole body 1.82 37 19 57.6 0.12 4.7e-01 ADAM15 ADCY3 ANKRD11 ARNT CADM2 CERS2 CYBRD1 DBNDD1 GDF5 HORMAD1 IGHMBP2 LINC00886 MAFF MANBAL MED20 MLXIPL MMP24-AS1 NCOA6 NRBP1 POMC PRELID1 PROCR PXMP4 RALY RBBP5 RBM39 RP11-15I11.3 RP11-316M1.12 RP11-443B20.1 RP11-54A4.2 RP11-554A11.9 RP5-966M1.6 RPL13 SOX6 TP53INP2 TPCN2 USP35
Leg fat mass (left) 1.48 11 5 15.2 -0.07 8.1e-01 ADAM15 ADCY3 CADM2 DNAJC27 EHBP1 MAFF POMC PXMP4 RALY RP11-443B20.1 TSPY26P
Arm predicted mass (left) 2.66 35 22 66.7 -0.40 1.1e-02 ADAM15 ANKRD11 CADM2 CBFA2T2 CHMP4B CYBRD1 E2F1 EHBP1 GDF5 IGHMBP2 IRF4 MAP1LC3A MED20 MLXIPL MMP24 MMP24-AS1 NCOA6 NKX2-2 NRBP1 PARP10 PRELID1 PROCR PXMP4 RALY RBM39 RPL13 RPN2 SNX11 TLDC2 TP53INP2 TPCN2 TRIP11 TRPS1 TYRP1 VPS9D1

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 45 1.289 16.92
GTEx Adipose Visceral Omentum 24 1.178 9.05
GTEx Adrenal Gland 29 1.990 29.43
GTEx Artery Aorta 41 1.377 15.11
GTEx Artery Coronary 10 0.845 17.61
GTEx Artery Tibial 44 1.171 12.98
GTEx Brain Caudate basal ganglia 14 1.522 4.12
GTEx Brain Cerebellar Hemisphere 25 1.679 30.40
GTEx Brain Cerebellum 30 1.513 30.59
GTEx Brain Cortex 17 1.644 34.97
GTEx Brain Frontal Cortex BA9 17 1.838 9.78
GTEx Brain Hippocampus 8 1.524 5.10
GTEx Brain Hypothalamus 11 1.861 12.75
GTEx Brain Nucleus accumbens basal ganglia 12 1.386 6.80
GTEx Brain Putamen basal ganglia 10 1.603 5.13
GTEx Breast Mammary Tissue 31 1.570 9.67
GTEx Breast Mammary Tissue (Male) 21 1.760 25.06
GTEx Breast Mammary Tissue (Female) 29 1.763 13.53
GTEx Cells EBV-transformed lymphocytes 24 1.689 5.84
GTEx Cells Transformed fibroblasts 62 1.477 12.88
GTEx Colon Sigmoid 21 1.435 27.64
GTEx Colon Transverse 25 1.211 19.10
GTEx Esophagus Gastroesophageal Junction 17 1.176 9.33
GTEx Esophagus Mucosa 44 1.325 10.10
GTEx Esophagus Muscularis 46 1.423 16.31
GTEx Heart Atrial Appendage 23 1.456 20.65
GTEx Heart Left Ventricle 20 1.306 19.00
GTEx Liver 12 1.674 4.43
GTEx Lung 38 1.323 14.81
GTEx Muscle Skeletal 44 1.521 10.77
GTEx Nerve Tibial 57 1.318 13.08
GTEx Ovary 11 1.210 13.11
GTEx Pancreas 29 1.776 19.25
GTEx Pituitary 18 1.613 22.55
GTEx Prostate 12 1.439 16.44
GTEx Skin Not Sun Exposed Suprapubic 39 1.585 21.73
GTEx Skin Sun Exposed Lower leg 56 1.540 12.77
GTEx Small Intestine Terminal Ileum 7 1.515 24.74
GTEx Spleen 17 1.205 15.91
GTEx Stomach 19 1.306 33.44
GTEx Testis 46 1.457 11.01
GTEx Thyroid 54 1.351 15.45
GTEx Uterus 8 1.411 11.16
GTEx Vagina 7 1.102 6.77
GTEx Whole Blood 34 1.709 11.15
METSIM Adipose 54 1.173 14.30
NTR Blood 24 0.999 4.60
ROSMAP Brain Pre-frontal Cortex 39 0.888 3.71
YFS Blood 41 0.888 6.19
CommonMind Brain Pre-frontal Cortex 74 1.376 12.71
TCGA Breast Tumor 7 0.914 2.08
TCGA Breast Normal 44 1.046 10.27
TCGA Ovarian Tumor 27 0.924 7.77
TCGA Prostate Tumor 36 1.041 6.51